Galeterone activity in castration-resistant prostate cancer

The Lancet. Oncology

Volumn 16, Issue 1, 2015, Pages e10-

  Yaqub, Farhat ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROGEN RECEPTOR ANTAGONIST; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AR PROTEIN, HUMAN;

DRUG EFFECTS; HUMAN; MALE; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANDROGEN RECEPTOR ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MALE; MOLECULAR TARGETED THERAPY; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84926099964     PISSN: None     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)71165-9     Document Type: Note

References (0)